A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation
Chiara Acchioni(Istituto Superiore di Sanità), Marco Sgarbanti(Istituto Superiore di Sanità), Giulia Marsili(Istituto Superiore di Sanità), Maria Letizia Barreca(University of Perugia), Giuseppe Manfroni(University of Perugia), Valentina Tirelli(Istituto Superiore di Sanità), Marta Acchioni(Istituto Superiore di Sanità), Mohamed Mysara(Belgian Nuclear Research Centre), Monica Bisbocci(IRBM Science Park), Mahmoud ElHefnawi(National Informatics Centre), Chin Piaw Gwee(Duke-NUS Medical School), Subhash G. Vasudevan(Duke-NUS Medical School), Flavia Mancini(Istituto Superiore di Sanità), Massimo Sanchez(Istituto Superiore di Sanità), Giulietta Venturi(Istituto Superiore di Sanità), Alberto Bresciani(University of Bergamo), Kitti Wing Ki Chan(Duke-NUS Medical School), Silvia Sandini(Istituto Superiore di Sanità), Antonello Amendola(Istituto Superiore di Sanità)
Cited by 18
Related Papers
Adipogenesis of skeletal muscle fibro/adipogenic progenitors is affected by the WNT5a/GSK3/β-catenin axis
|Cell Death and Differentiation|2020|149
Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication
|PLoS Pathogens|2016|126
Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo
|Antiviral Research|2014|118
Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington’s disease
|Journal of Clinical Investigation|2019|101
Novel antiviral activity of bromocriptine against dengue virus replication
|Antiviral Research|2016|84